Publication

Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial.

Journal Paper/Review - Jul 1, 2024

PubMed
Doi
Contact

Citation
Goeldlin M, Hakim A, Branca M, Abend S, Kneihsl M, Valenzuela Pinilla W, Fenzl S, Rezny-Kasprzak B, Rohner R, Strbian D, Paciaroni M, Thomalla G, Michel P, Nedeltchev K, Gattringer T, Sandset E, Bonati L, Maurice De Sousa D, Sylaja P, Ntaios G, Koga M, Gdovinova Z, Lemmens R, Bornstein N, Kelly P, Katan M, Horvath T, Dawson J, Fischer U, ELAN Investigators. Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial. JAMA Neurol 2024; 81:693-702.
Type
Journal Paper/Review (English)
Journal
JAMA Neurol 2024; 81
Publication Date
Jul 1, 2024
Issn Electronic
2168-6157
Pages
693-702
Brief description/objective

Whether infarct size modifies the treatment effect of early vs late direct oral anticoagulant (DOAC) initiation in people with ischemic stroke and atrial fibrillation is unknown.